Congress Weighs Repeal of Tax Credit for Rare Disease Drugs

Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News